These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 11335880

  • 1. Hashimoto's disease during interferon-alpha therapy in a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease.
    Martocchia A, Labbadia G, Paoletti V, Gargano S, Grossi A, Trabace S, Musca A, Falaschi P.
    Neuro Endocrinol Lett; 2001; 22(1):49-52. PubMed ID: 11335880
    [Abstract] [Full Text] [Related]

  • 2. Association between human leukocyte antigen (HLA) and interferon- induced thyroid diseases in four patients with HCV-related chronic hepatitis.
    Labbadia G, Martocchia A, Mammarella A, Paoletti V, Rocco A, Benvenuto R, Antonella P, Rosaria D, Trabace S, Musca A, Falaschi P.
    Neuro Endocrinol Lett; 2005 Apr; 26(2):109-12. PubMed ID: 15855880
    [Abstract] [Full Text] [Related]

  • 3. Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection.
    Rocco A, Gargano S, Provenzano A, Nardone M, De Sanctis GM, Altavilla N, Chircu LV, Grimaldi F.
    Neuro Endocrinol Lett; 2001 Apr; 22(1):39-44. PubMed ID: 11335878
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice.
    Kawai K, Enomoto T, Fornasier V, Resetkova E, Volpé R.
    Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581
    [Abstract] [Full Text] [Related]

  • 5. The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification.
    Mandac JC, Chaudhry S, Sherman KE, Tomer Y.
    Hepatology; 2006 Apr; 43(4):661-72. PubMed ID: 16557537
    [Abstract] [Full Text] [Related]

  • 6. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
    Zwirska-Korczala K, Berdowska A, Jochem J, Sitkiewicz A, Birkner E, Polaniak R, Jedrzejowska-Szypułka H, Korzonek-Szlacheta I.
    J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
    [Abstract] [Full Text] [Related]

  • 7. Polyspecificity of antimicrosomal thyroid antibodies in hepatitis C virus-related infection.
    Peoc'h K, Dubel L, Chazouillères O, Ocwieja T, Duron F, Poupon R, Johanet C.
    Am J Gastroenterol; 2001 Oct; 96(10):2978-83. PubMed ID: 11693336
    [Abstract] [Full Text] [Related]

  • 8. High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-alpha.
    Matsuda J, Saitoh N, Gotoh M, Gohchi K, Tsukamoto M, Syoji S, Miyake K, Yamanaka M.
    Am J Gastroenterol; 1995 Jul; 90(7):1138-41. PubMed ID: 7611213
    [Abstract] [Full Text] [Related]

  • 9. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
    Bargiggia S, Thorburn D, Anderloni A, Ardizzone S, Giorgi A, Bianchi Porro G, Parente F.
    Aliment Pharmacol Ther; 2005 Aug 01; 22(3):209-15. PubMed ID: 16091058
    [Abstract] [Full Text] [Related]

  • 10. Types of human leukocyte antigen and decrease in HCV core antigen in serum for predicting efficacy of interferon-Alpha in patients with chronic hepatitis C: analysis by a prospective study.
    Muto H, Tanaka E, Matsumoto A, Yoshizawa K, Kiyosawa K, Nagano Interferon Treatment Research Group.
    J Gastroenterol; 2004 Jul 01; 39(7):674-80. PubMed ID: 15293139
    [Abstract] [Full Text] [Related]

  • 11. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N.
    Clin Transplant; 2006 Jul 01; 20(6):677-83. PubMed ID: 17100715
    [Abstract] [Full Text] [Related]

  • 12. Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha.
    Kansu A, Kuloğlu Z, Demirçeken F, Girgin N.
    Turk J Gastroenterol; 2004 Dec 01; 15(4):213-8. PubMed ID: 16249973
    [Abstract] [Full Text] [Related]

  • 13. Thyroid dysfunction in antiviral therapy of chronic hepatitis C.
    Dabrowska MM, Panasiuk A, Flisiak R.
    Hepatogastroenterology; 2010 Dec 01; 57(101):826-31. PubMed ID: 21033237
    [Abstract] [Full Text] [Related]

  • 14. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
    Alvarado Esquivel C, Elewaut A, Philippé J, Elewaut AE, Desombere I, Maertens G, Leroux-Roels G.
    Rev Invest Clin; 2002 Dec 01; 54(1):41-50. PubMed ID: 11995406
    [Abstract] [Full Text] [Related]

  • 15. [Thyroid disorders associated with interferon treatment in patients with chronic viral hepatitis or multiple sclerosis].
    Diago JI, del Olmo D, Alcázar V, Martínez de Icaya P, Rodríguez E, Martínez Montiel P.
    Med Clin (Barc); 1999 Jun 19; 113(2):50-1. PubMed ID: 10425619
    [Abstract] [Full Text] [Related]

  • 16. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL, Dai CY, Chang WY, Lee LP, Lin ZY, Chen SC, Hsieh MY, Wang LY, Yu ML.
    Antivir Ther; 2005 Jun 19; 10(1):125-33. PubMed ID: 15751770
    [Abstract] [Full Text] [Related]

  • 17. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy.
    Tran A, Quaranta JF, Benzaken S, Thiers V, Chau HT, Hastier P, Regnier D, Dreyfus G, Pradier C, Sadoul JL.
    Hepatology; 1993 Aug 19; 18(2):253-7. PubMed ID: 7687977
    [Abstract] [Full Text] [Related]

  • 18. [Autoantibodies against islet cell antigens and type 1 diabetes after treatment with interferon-alpha].
    Schories M, Peters T, Rasenack J, Reincke M.
    Dtsch Med Wochenschr; 2004 May 14; 129(20):1120-4. PubMed ID: 15143453
    [Abstract] [Full Text] [Related]

  • 19. Long-term follow-up after successful interferon therapy of acute hepatitis C.
    Wiegand J, Jäckel E, Cornberg M, Hinrichsen H, Dietrich M, Kroeger J, Fritsch WP, Kubitschke A, Aslan N, Tillmann HL, Manns MP, Wedemeyer H.
    Hepatology; 2004 Jul 14; 40(1):98-107. PubMed ID: 15239091
    [Abstract] [Full Text] [Related]

  • 20. The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon-alpha and ribavirin combination therapy.
    Huang JF, Chuang WL, Dai CY, Chen SC, Lin ZY, Lee LP, Lee PL, Wang LY, Hsieh MY, Chang WY, Yu ML.
    J Viral Hepat; 2006 Jun 14; 13(6):396-401. PubMed ID: 16842442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.